In vitro activities of six new fluoroquinolones against Brucella melitensis

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 194-195

  Trujillano Martín, Ignacio ^a   García Sánchez, Enrique ^a   Martínez, Isaías Montes ^b   Fresnadillo, María José ^a   García Sánchez, José Elías ^a   García Rodríguez, José Ángel ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL VIRGEN DEL PUERTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; GATIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SITAFLOXACIN; STREPTOMYCIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BRUCELLA MELITENSIS; BRUCELLOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0344572871     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.194     Document Type: Article

References (19)

1. Acocella, G., A. Bertrand, J. Beytout, J. B. Durrande, J. A. García-Rodŕguez, J. Kosmidis, M. Micoud, M. Rey, M. Rodríguez Zapata, J. Roux, and J. P. Stahl. 1990. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J. Antimicrob. Chemother. 23:433-439.
2. Al-Sibai, M. B., and S. M. H. Qadri. 1990. Development of ciprofloxacin resistance in Brucella melitensis. J. Antimicrob. Chemother. 25:302-303.
3. Al-Sibai, M. B., M. A. Halim, M. M. El-Shaker, B. A. Khan, and S. M. H. Qadri. 1992. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. Antimicrob. Agents Chemother. 36:150-152.
4. Bergan, T. 1998. Pharmacokinetics of the fluoroquinolones, p. 143-182. In V. T. Andriole (ed.). The quinolones, 2nd ed. Academic Press, San Diego, Calif.
5. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-12.
6. Easmon, C. S. F., J. P. Crane, and A. Blowers. 1986. Effect of ciprofloxacin on intracellular organisms. In-vitro and in-vivo studies. J. Antimicrob. Chemother. 18(Suppl. D):43-48.
7. García-Rodríguez, J. A., J. E. García-Sánchez, J. L. Muñoz Bellido, E. García-Sánchez, and I. Trujillano. 1989. Kinetics of antimicrobial activity of ciprofloxacin against Brucella melitensis. Rev. Esp. Quimioter. 2:61-63.
8. García-Rodríguez, J. A., J. E. García-Sánchez, and I. Trujillano. 1991. Lack of effective bactericidal activity of new quinolones against Brucella spp. Antimicrob. Agents Chemother. 35:756-759.
9. García-Rodríguez, J. A., J. E. García-Sánchez, I. Trujillano, and J. L. Muñoz Bellido. 1989. In-vitro activity of new quinolones against Brucella melitensis. Rev. Infect. Dis. 11(Suppl. 5):S992-S993.
10. García-Rodríguez, J. A., J. E. García Sánchez, I. Trujillano, E. García Sánchez, M. I. García García, and M. J. Fresnadillo. 1995. Susceptibilities of Brucella melitensis isolates to clinaftoxacin and four other new fluoroquinolones. Antimicrob. Agents Chemother. 39:1194-1195.
11. Garća-Rodríguez, J. A., J. E. García-Sánchez, I. Trujillano-Martín, E. García-Sánchez, M. I. García-García, and M. J. Fresnadillo-Marínez. 1995. In-vitro activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis. J. Chemother. 7:189-196.
12. Gobernado, M., E. Cantón, and M. Santos. 1984. In-vitro activity of ciprofloxacin against Brucella melitensis. Eur. J. Clin. Microbiol. 3:371.
13. Kalo, T., S. Novi, A. Nushi, and S. Dedja. 1996. Ciprofloxacin plus doxycycline versus rifampicin plus doxycycline in the treatment of acute brucellosis. Méd. Maladies Infect. 26:587-589.
14. Kosmidis, J., A. Karagouis, J. Tslentis, and G. K. Daikos. 1982. The combination rifampin-doxycycline in brucellosis is better than the WHO regimen. Chemioterapia 1(Suppl. 4):107.
15. Lang, R., M. Banai, M. Lishner, and E. Rubinstein. 1995. Brucellosis. Int. J. Antimicrob. Agents 5:203-208.
16. Moyer, N. P., and L. A. Holcomb. 1995. Brucella, p. 549-555. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
17. Qadri, S. M., M. Akhtar, Y. Ueno, and M. B. Al-Sibai. 1989. Susceptibility of Brucella melitensis to fluoroquinolones. Drugs Exp. Clin. Res. 15:483-485.
18. Qadri, S. M., S. Al-Sedairy, and Y. Ueno. 1990. Antibacterial activity of lomefloxacin against Brucella melitensis. Diagn. Microbiol. Infect. Dis. 13: 277-279.
19. Qadri, S. M., and Y. Ueno. 1993. Susceptibility of Brucella melitensis to new fluoroquinolone PD 131628: comparison with other drugs. Microbiology 39: 128-131.